Lilly’s Kisunla: Labeling Allows For Stopping Treatment Based On Amyloid Plaque Reduction

 
• By Sue Sutter
Stop light
Patients may stop taking Kisunla when amyloid plaque is reduced to 'minimal levels' on PET imaging. • Source: Shutterstock

More from Approvals

More from Product Reviews